PepLib
PepLib is a biotech company specializing in peptide drug discovery. Using an advanced platform that combines mRNA display, macrocyclic phage display, and AI-driven design, PepLib develops potent peptide radioligands with strong tumor retention and high T/K ratio. Its pipeline includes 30+ programs targeting FAP, GPC3, Trop2, DLL3, and other tumor-specific targets. With a flexible partnership model, PepLib actively seeks collaborations and out-licensing opportunities to advance innovative peptide radioligand therapy.
